MIND MEDICINE MINDMED INC (MNMD) Stock Analyst Earnings Estimates
NASDAQ:MNMD - Nasdaq - CA60255C8850 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 499.94% | N/A 122.52% | N/A 59.28% | N/A 23.46% | N/A -1.37% | |||||||||||
| EBITDA YoY % growth | N/A | N/A | -150K | -1.22M -713.33% | -850K 30.33% | -460K 45.88% | -33.03M -7,080.43% | -91.23M -176.20% | -63.15M 30.78% | -90.704M -43.63% | -103.389M -13.99% | N/A -39.85% | N/A -16.97% | N/A 14.08% | N/A 90.31% | N/A 1,237.33% | N/A 199.90% | N/A 1.47% | N/A 54.44% | |
| EBIT YoY % growth | -70K | -50K 28.57% | -150K -200.00% | -1.23M -720.00% | -860K 30.08% | -470K 45.35% | -33.03M -6,927.66% | -93.85M -184.14% | -66.33M 29.32% | -93.866M -41.51% | -103.916M -10.71% | N/A -52.91% | N/A -13.03% | N/A 6.42% | N/A 110.80% | N/A 1,055.73% | N/A 123.95% | N/A 46.90% | N/A -3.09% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A -106.06% | -1.92 44.64% | -2.32 -20.83% | -2.08 10.34% | N/A 29.63% | N/A -12.72% | N/A 11.50% | N/A 83.35% | N/A 596.01% | N/A 123.52% | N/A 47.39% | N/A -20.01% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.45 -67.48% | -0.47 -13.89% | -0.41 -52.37% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | -30.498M -25.69% | -31.671M 0.83% | N/A |
| EBIT Q2Q % growth | -38.906M -56.93% | -40.493M -24.74% | -34.674M -7.82% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.50 -92.31% | -0.37 | -0.13 | -34.51% |
| Q1 2025 Q2Q % growth | -0.27 76.32% | -0.37 | 0.10 | 27.56% |
| Q4 2024 Q2Q % growth | -0.41 30.51% | -0.30 | -0.11 | -35.89% |
| Q3 2024 Q2Q % growth | -0.27 40.00% | -0.29 | 0.02 | 5.46% |
| Q2 2024 Q2Q % growth | -0.26 65.79% | -0.34 | 0.08 | 22.50% |
| Q1 2024 Q2Q % growth | -1.14 -119.23% | -0.54 | -0.60 | -111.45% |
| Q4 2023 Q2Q % growth | -0.59 -268.75% | -0.47 | -0.12 | -24.97% |
| Q3 2023 Q2Q % growth | -0.45 19.64% | -0.69 | 0.24 | 34.64% |
| Q2 2023 Q2Q % growth | -0.76 -26.67% | -0.55 | -0.21 | -38.84% |
| Q1 2023 Q2Q % growth | -0.52 13.33% | -0.43 | -0.09 | -20.24% |
| Q4 2022 Q2Q % growth | -0.16 -220.00% | -0.51 | 0.35 | 68.84% |
| Q3 2022 Q2Q % growth | -0.56 | -0.61 | 0.05 | 7.88% |
| Q2 2022 Q2Q % growth | -0.60 | -0.77 | 0.17 | 21.57% |
| Q1 2022 Q2Q % growth | -0.60 | -0.77 | 0.17 | 21.57% |
| Q4 2021 Q2Q % growth | -0.05 66.67% | -0.97 | 0.92 | 94.83% |
| Q4 2020 Q2Q % growth | -0.15 | -0.31 | 0.16 | 50.98% |
| Q3 2020 Q2Q % growth | -0.45 | -0.46 | 0.01 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.3% | 1.8% | 2.85% | 8.35% |
| Revenue | N/A | N/A | N/A | N/A |